-
2
-
-
0018379162
-
Achondroplasia and hypochondroplasia
-
Oberklaid F, Danks DM, Jensen F, Stace L, Rosshandler S: Achondroplasia and hypochondroplasia. J Med Genet 1979;16:140-146.
-
(1979)
J Med Genet
, vol.16
, pp. 140-146
-
-
Oberklaid, F.1
Danks, D.M.2
Jensen, F.3
Stace, L.4
Rosshandler, S.5
-
3
-
-
50549219325
-
Long-term treatment of hypopitu-itary and of achondroplastic dwarfism with human growth hormone
-
Gershberg H, Mari S, Hulse M, St Paul H: Long-term treatment of hypopitu-itary and of achondroplastic dwarfism with human growth hormone. Metabo-lism 1964;13:152-160.
-
(1964)
Metabo-lism
, vol.13
, pp. 152-160
-
-
Gershberg, H.1
Mari, S.2
Hulse, M.3
St Paul, H.4
-
4
-
-
0142244524
-
Efficacy of growth hormone therapy for patients with skeletal dysplasia
-
Kanazawa H, Tanaka H, Inoue M, Ya-manaka Y, Namba N, Seino Y: Efficacy of growth hormone therapy for patients with skeletal dysplasia. J Bone Miner Res 2003;21:307-310.
-
(2003)
J Bone Miner Res
, vol.21
, pp. 307-310
-
-
Kanazawa, H.1
Tanaka, H.2
Inoue, M.3
Ya-manaka, Y.4
Namba, N.5
Seino, Y.6
-
5
-
-
0141995074
-
Effect of 24 months of recombinant growth hormone on height and body proportions in SHOX haploinsufficien-cy
-
Munns CF, Berry M, Vickers D, Rap-pold GA, Hyland VJ, Glass IA, Batch JA: Effect of 24 months of recombinant growth hormone on height and body proportions in SHOX haploinsufficien-cy. J Pediatr Endocrinol Metab 2003;16:997-1004.
-
(2003)
J Pediatr Endocrinol Metab
, vol.16
, pp. 997-1004
-
-
Munns, C.F.1
Berry, M.2
Vickers, D.3
Rap-pold, G.A.4
Hyland, V.J.5
Glass, I.A.6
Batch, J.A.7
-
7
-
-
0346749736
-
Skeletal dysplasia, growth hormone treatment and body proportions: comparison with other syndromic and non-syndromic short children
-
Hagenäs L, Hertel T: Skeletal dysplasia, growth hormone treatment and body proportions: comparison with other syndromic and non-syndromic short children. Horm Res 2003;60:65-70.
-
(2003)
Horm Res
, vol.60
, pp. 65-70
-
-
Hagenäs, L.1
Hertel, T.2
-
8
-
-
1842848098
-
Fibroblast growth factor receptor 3 mutations in achondroplasia and related forms of dwarfism
-
Horton WA, Lunstrum GP: Fibroblast growth factor receptor 3 mutations in achondroplasia and related forms of dwarfism. Rev Endocr Metab Disord 2002;3:381-385.
-
(2002)
Rev Endocr Metab Disord
, vol.3
, pp. 381-385
-
-
Horton, W.A.1
Lunstrum, G.P.2
-
9
-
-
0027964261
-
Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia
-
Shiang R, Thompson LM, Zhu YZ, Church DM, Fielder TJ, Bocian M, Wi-nokur ST, Wasmuth JJ: Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 1994;78:335-342.
-
(1994)
Cell
, vol.78
, pp. 335-342
-
-
Shiang, R.1
Thompson, L.M.2
Zhu, Y.Z.3
Church, D.M.4
Fielder, T.J.5
Bocian, M.6
Wi-nokur, S.T.7
Wasmuth, J.J.8
-
10
-
-
0037097976
-
FGF signaling pathways in endochondral and intra-membranous bone development and human genetic disease
-
Ornitz DM, Marie PJ: FGF signaling pathways in endochondral and intra-membranous bone development and human genetic disease. Genes Dev 2002;16:1446-1465.
-
(2002)
Genes Dev
, vol.16
, pp. 1446-1465
-
-
Ornitz, D.M.1
Marie, P.J.2
-
11
-
-
0017807899
-
Standard growth curves for achondroplasia
-
Horton WA, Rotter JI, Rimoin DL, Scott CI Jr, Hall JG: Standard growth curves for achondroplasia. J Pediatr 1978;93:435-438.
-
(1978)
J Pediatr
, vol.93
, pp. 435-438
-
-
Horton, W.A.1
Rotter, J.I.2
Rimoin, D.L.3
Scott Jr., C.I.4
Hall, J.G.5
-
12
-
-
27144547212
-
Growth hormone treatment in 35 pre-pubertal children with achondroplasia: a five-year dose-response trial
-
Hertel NT, Eklof O, Ivarsson S, Aron-son S, Westphal O, Sipila I, Kaitila I, Bland J, Veimo D, Muller J, Mohnike K, Neumeyer L, Ritzen M, Hagenas L: Growth hormone treatment in 35 pre-pubertal children with achondroplasia: a five-year dose-response trial. Acta Paediatr 2005;94:1402-1410.
-
(2005)
Acta Paediatr
, vol.94
, pp. 1402-1410
-
-
Hertel, N.T.1
Eklof, O.2
Ivarsson, S.3
Aron-son, S.4
Westphal, O.5
Sipila, I.6
Kaitila, I.7
Bland, J.8
Veimo, D.9
Muller, J.10
Mohnike, K.11
Neumeyer, L.12
Ritzen, M.13
Hagenas, L.14
-
13
-
-
0026510663
-
Growth hormone therapy in achondro-plasia
-
Horton WA, Hecht JT, Hood OJ, Mar-shall RN, Moore WV, Hollowell JG: Growth hormone therapy in achondro-plasia. Am J Med Genet 1992;42:667-670.
-
(1992)
Am J Med Genet
, vol.42
, pp. 667-670
-
-
Horton, W.A.1
Hecht, J.T.2
Hood, O.J.3
Mar-shall, R.N.4
Moore, W.V.5
Hollowell, J.G.6
-
14
-
-
0032822419
-
Treat-ment of achondroplasia with growth hormone: six years of experience
-
Ramaswami U, Rumsby G, Spoudeas HA, Hindmarsh PC, Brook CGD: Treat-ment of achondroplasia with growth hormone: six years of experience. Pedi-atr Res 1999;46:435-439.
-
(1999)
Pedi-atr Res
, vol.46
, pp. 435-439
-
-
Ramaswami, U.1
Rumsby, G.2
Spoudeas, H.A.3
Hindmarsh, P.C.4
Brook, C.G.D.5
-
15
-
-
0037296350
-
The comparison of the ef-fects of short-term growth hormone treatment in patients with achondro-plasia and with hypochondroplasia
-
Tanaka N, Katsumata N, Horikawa R, Tanaka T: The comparison of the ef-fects of short-term growth hormone treatment in patients with achondro-plasia and with hypochondroplasia. Endocr J 2003;50:69-75.
-
(2003)
Endocr J
, vol.50
, pp. 69-75
-
-
Tanaka, N.1
Katsumata, N.2
Horikawa, R.3
Tanaka, T.4
-
16
-
-
0033659625
-
Dis-tinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skel-etal dysplasia phenotype
-
Bellus GA, Spector EB, Speiser PW, Weaver CA, Garber AT, Bryke CR, Is-rael J, Rosengren SS, Webster MK, Donoghue DJ, Francomano CA: Dis-tinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skel-etal dysplasia phenotype. Am J Hum Genet 2000;67:1411-1421.
-
(2000)
Am J Hum Genet
, vol.67
, pp. 1411-1421
-
-
ellus, G.A.1
Spector, E.B.2
Speiser, P.W.3
Weaver, C.A.4
Garber, A.T.5
Bryke, C.R.6
Is-rael, J.7
Rosengren, S.S.8
Webster, M.K.9
Donoghue, D.J.10
Francomano, C.A.11
-
17
-
-
0032248556
-
A novel missense mutation Ile538Val in the fibroblast growth factor 3 in hypo-chondroplasia
-
Grigelioniené G, Hagenäs L, Eklöf O, Neumeyer L, Haereid PE, Anvret M: A novel missense mutation Ile538Val in the fibroblast growth factor 3 in hypo-chondroplasia. Hum Mutat 1998;11:333.
-
(1998)
Hum Mutat
, vol.11
, pp. 333
-
-
Grigelioniené, G.1
Hagenäs, L.2
Eklöf, O.3
Neumeyer, L.4
Haereid, P.E.5
Anvret, M.6
-
18
-
-
33751330697
-
Novel FGFR3 mutations creating cysteine residues in the extracellular domain of the receptor cause achondroplasia or severe forms of hypochondroplasia
-
Heuertz S, Le Merrer M, Zabel B, Wright M, Legeai-Mallet L, Cormier-Daire V, Gibbs L, Bonaventure J: Novel FGFR3 mutations creating cysteine residues in the extracellular domain of the receptor cause achondroplasia or severe forms of hypochondroplasia. Eur J Hum Genet 2006;14:1240-1247.
-
(2006)
Eur J Hum Genet
, vol.14
, pp. 1240-1247
-
-
Heuertz, S.1
Le Merrer, M.2
Zabel, B.3
Wright, M.4
Legeai-Mallet, L.5
Cormier-Daire, V.6
Gibbs, L.7
Bonaventure, J.8
-
19
-
-
0041320749
-
Hypochon-droplasia and stature within normal limits: another family with an Asn540Ser mutation in the fibroblast growth factor receptor 3 gene
-
Thauvin-Robinet C, Faivre L, Lewin P, De Monleon JV, Francois C, Huet F, Couailler JF, Campos-Xavier AB, Bo-naventure J, Le Merrer M: Hypochon-droplasia and stature within normal limits: another family with an Asn540Ser mutation in the fibroblast growth factor receptor 3 gene. Am J Med Genet 2003;119A:81-84.
-
(2003)
Am J Med Genet
, vol.119
, pp. 81-84
-
-
Thauvin-Robinet, C.1
Faivre, L.2
Lewin, P.3
De Monleon, J.V.4
Francois, C.5
Huet, F.6
Couailler, J.F.7
Campos-Xavier, A.B.8
Bo-naventure, J.9
Le Merrer, M.10
-
20
-
-
0034707489
-
A novel mutation in FGFR-3 disrupts a putative N-glyco-sylation site and results in hypochon-droplasia
-
Winterpacht A, Hilbert K, Stelzer C, Schweikardt T, Decker H, Segerer H, Spranger J, Zabel B: A novel mutation in FGFR-3 disrupts a putative N-glyco-sylation site and results in hypochon-droplasia. Physiol Genomics 2000;2:9.
-
(2000)
Physiol Genomics
, vol.2
, pp. 9
-
-
Winterpacht, A.1
Hilbert, K.2
Stelzer, C.3
Schweikardt, T.4
Decker, H.5
Segerer, H.6
Spranger, J.7
Zabel, B.8
-
21
-
-
0029032394
-
A recurrent mutation in the tyrosine ki-nase domain of fibroblast growth fac-tor 3 causes hypochondroplasia
-
Bellus GA, McIntosh I, Smith EA, Ayls-worth AS, Kaitila I, Horton WA, Green-haw GA, Hecht JT, Francomano CA: A recurrent mutation in the tyrosine ki-nase domain of fibroblast growth fac-tor 3 causes hypochondroplasia. Nat Genet 1995;10:357-359.
-
(1995)
Nat Genet
, vol.10
, pp. 357-359
-
-
Bellus, G.A.1
McIntosh, I.2
Smith, E.A.3
Ayls-worth, A.S.4
Kaitila, I.5
Horton, W.A.6
Green-haw, G.A.7
Hecht, J.T.8
Francomano, C.A.9
-
22
-
-
0025975265
-
Growth characteristics and response to growth hormone therapy in patients with hy-pochondroplasia: genetic linkage of the insulin-like growth factor I gene at chromosome 12q23 to the disease in a subgroup of these patients
-
Mullis PE, Patel MS, Brickell PM, Hindmarsh PC, Brook CGD: Growth characteristics and response to growth hormone therapy in patients with hy-pochondroplasia: genetic linkage of the insulin-like growth factor I gene at chromosome 12q23 to the disease in a subgroup of these patients. Clin Endo-crinol 1991;34:265-274.
-
(1991)
Clin Endo-crinol
, vol.34
, pp. 265-274
-
-
Mullis, P.E.1
Patel, M.S.2
Brickell, P.M.3
Hindmarsh, P.C.4
Brook, C.G.D.5
-
23
-
-
0025027309
-
Growth and growth hormone therapy in hypo-chondroplasia
-
Appan S, Laurent S, Chapman M, Hindmarsh PC, Brook CGD: Growth and growth hormone therapy in hypo-chondroplasia. Acta Paediatr Scand 1990;79:796-803.
-
(1990)
Acta Paediatr Scand
, vol.79
, pp. 796-803
-
-
Appan, S.1
Laurent, S.2
Chapman, M.3
Hindmarsh, P.C.4
Brook, C.G.D.5
-
24
-
-
20944436622
-
Dis-proportionate stature but normal height in hypochondroplasia
-
Riepe FG, Krone N, Sippell WG: Dis-proportionate stature but normal height in hypochondroplasia. Eur J Pe-diatr 2005;164:397-399.
-
(2005)
Eur J Pe-diatr
, vol.164
, pp. 397-399
-
-
Riepe, F.G.1
Krone, N.2
Sippell, W.G.3
-
25
-
-
0026316869
-
Growth of children with hypochondro-plasia treated with growth hormone for up to three years
-
Bridges NA, Hindmarsh P, Brook CGD: Growth of children with hypochondro-plasia treated with growth hormone for up to three years. Horm Res 1991;36(suppl 1):56-60.
-
(1991)
Horm Res
, vol.36
, Issue.SUPPL. 1
, pp. 56-60
-
-
Bridges, N.A.1
Hindmarsh, P.2
Brook, C.G.D.3
-
27
-
-
84882048652
-
Three years of growth hormone treatment in 33 prepubertal children with hypo-chondroplasia
-
Hertel NT, Hagenäs L, Otten BJ, De Schepper J, Gregory JW, Sipilä I: Three years of growth hormone treatment in 33 prepubertal children with hypo-chondroplasia. The KIGS experience. Horm Res 2005;64(suppl 1):51.
-
(2005)
The KIGS experience. Horm Res
, vol.64
, Issue.SUPPL 1
, pp. 51
-
-
Hertel, N.T.1
Hagenäs, L.2
Otten, B.J.3
De Schepper, J.4
Gregory, J.W.5
Sipilä, I.6
-
28
-
-
0037340318
-
Final height in girls with Turner syn-drome after long-term growth hor-mone treatment in three dosages and low dose estrogens
-
van Pareren YK, de Muinck Keizer-Schrama S, Stijnen T, Sas TCJ, Jansen M, Otten BJ, Hoorweg-Nijman JJG, Vulsma T, Stokvis-Brantsma WH, Rou-we CW, Reeser HM, Gerver WJ, Gosen JJ, Rongen-Westerlaken C, Drop SLS: Final height in girls with Turner syn-drome after long-term growth hor-mone treatment in three dosages and low dose estrogens. J Clin Endocrinol Metab 2003;88:1119-1125.
-
(2003)
J Clin Endocrinol Metab
, vol.88
, pp. 1119-1125
-
-
van Pareren, Y.K.1
de Muinck Keizer-Schrama, S.2
Stijnen, T.3
Sas, T.C.J.4
Jansen, M.5
Otten, B.J.6
Hoorweg-Nijman, J.J.G.7
Vulsma, T.8
Stokvis-Brantsma, W.H.9
Rou-we, C.W.10
Reeser, H.M.11
Gerver, W.J.12
Gosen, J.J.13
Rongen-Westerlaken, C.14
Drop, S.L.S.15
-
29
-
-
17344363774
-
SHOX mutations in dyschondroste-osis (Leri-Weill syndrome)
-
Belin V, Cusin V, Viot G, Girlich D, Toutain A, Moncla A, Vekemans M, Le Merrer M, Munnich A, Cormier-Daire V: SHOX mutations in dyschondroste-osis (Leri-Weill syndrome). Nat Genet 1998;19:67-69.
-
(1998)
Nat Genet
, vol.19
, pp. 67-69
-
-
Belin, V.1
Cusin, V.2
Viot, G.3
Girlich, D.4
Toutain, A.5
Moncla, A.6
Vekemans, M.7
Le Merrer, M.8
Munnich, A.9
Cormier-Daire, V.10
-
30
-
-
4544383265
-
SHOX haploinsufficiency and Leri-Weill dyschondrosteosis: prevalence and growth failure in rela-tion to mutation, sex, and degree of wrist deformity
-
Binder G, Renz A, Martinez A, Kesel-man A, Hesse V, Riedl SW, Hausler G, Fricke-Otto S, Frisch H, Heinrich JJ, Ranke MB: SHOX haploinsufficiency and Leri-Weill dyschondrosteosis: prevalence and growth failure in rela-tion to mutation, sex, and degree of wrist deformity. J Clin Endocrinol Metab 2004;89:4403-4408.
-
(2004)
J Clin Endocrinol Metab
, vol.89
, pp. 4403-4408
-
-
Binder, G.1
Renz, A.2
Martinez, A.3
Kesel-man, A.4
Hesse, V.5
Riedl, S.W.6
Hausler, G.7
Fricke-Otto, S.8
Frisch, H.9
Heinrich, J.J.10
Ranke, M.B.11
-
31
-
-
0033431823
-
SHOX gene mutations and deletions in dys-chondrosteosis or Leri-Weill syndrome
-
Cormier-Daire V, Belin V, Cusin V, Viot G, Girlich D, Toutain A, Moncla A, Ve-kemans M, Le MM, Munnich A: SHOX gene mutations and deletions in dys-chondrosteosis or Leri-Weill syndrome. Acta Paediatr Suppl 1999;88:55-59.
-
(1999)
Acta Paediatr Suppl
, vol.88
, pp. 55-59
-
-
Cormier-Daire, V.1
Belin, V.2
Cusin, V.3
Viot, G.4
Girlich, D.5
Toutain, A.6
Moncla, A.7
Ve-kemans, M.8
Le, M.M.9
Munnich, A.10
-
32
-
-
0035177711
-
Analysis of short stature homeobox-containing gene (SHOX) and auxologi-cal phenotype in dyschondrosteosis and isolated Madelung deformity
-
Grigelioniené G, Schoumans J, Neu-meyer L, Ivarsson SA, Eklöf O, Enkvist O, Tordai P, Fosdal I, Myhre AG, West-phal O, Nilsson Nö, Elfving M, Ellis I, Anderlid BM, Fransson I, Tapia-Paez I, Nordenskjöld M, Hagenäs L, Dumanski JP: Analysis of short stature homeobox-containing gene (SHOX) and auxologi-cal phenotype in dyschondrosteosis and isolated Madelung deformity. Hum Genet 2001;109:551-558.
-
(2001)
Hum Genet
, vol.109
, pp. 551-558
-
-
Grigelioniené, G.1
Schoumans, J.2
Neu-meyer, L.3
Ivarsson, S.A.4
Eklöf, O.5
Enkvist, O.6
Tordai, P.7
Fosdal, I.8
Myhre, A.G.9
West-phal, O.10
Nilsson, N.Ö.11
Elfving, M.12
Ellis, I.13
Anderlid, B.M.14
Fransson, I.15
Tapia-Paez, I.16
Nordenskjöld, M.17
Hagenäs, L.18
Dumanski, J.P.19
-
33
-
-
0032888428
-
SHOX: pseudoautosomal ho-meobox containing gene for short stat-ure and dyschondrosteosis
-
Ogata T: SHOX: pseudoautosomal ho-meobox containing gene for short stat-ure and dyschondrosteosis. Growth Horm IGF Res 1999;9(suppl B):53-57.
-
(1999)
Growth Horm IGF Res
, Issue.SUPPL. B
, pp. 53-57
-
-
Ogata, T.1
-
34
-
-
0036908813
-
SHOX haploinsufficiency and its modifying factors
-
Ogata T: SHOX haploinsufficiency and its modifying factors. J Pediatr Endo-crinol Metab 2002;15(suppl 5):1289-1294.
-
(2002)
J Pediatr Endo-crinol Metab
, vol.15
, Issue.SUPPL. 5
, pp. 1289-1294
-
-
Ogata, T.1
-
35
-
-
10744226905
-
Familial growth and skeletal features associated with SHOX haploinsufficiency
-
Munns CF, Glass IA, Flanagan S, Hayes M, Williams B, Berry M, Vickers D, O'Rourke P, Rao E, Rappold GA, Hy-land VJ, Batch JA: Familial growth and skeletal features associated with SHOX haploinsufficiency. J Pediatr Endocri-nol Metab 2003;16:987-996.
-
(2003)
J Pediatr Endocri-nol Metab
, vol.16
, pp. 987-996
-
-
Munns, C.F.1
Glass, I.A.2
Flanagan, S.3
Hayes, M.4
Williams, B.5
Berry, M.6
Vickers, D.7
O'Rourke, P.8
Rao, E.9
Rappold, G.A.10
Hy-land, V.J.11
Batch, J.A.12
-
36
-
-
18044379322
-
Phenotypes associated with SHOX defi-ciency
-
Ross JL, Scott C Jr, Marttila P, Kowal K, Nass A, Papenhausen P, Abboudi J, Os-terman L, Kushner H, Carter P, Ezaki M, Elder F, Wei F, Chen H, Zinn AR: Phenotypes associated with SHOX defi-ciency. J Clin Endocrinol Metab 2001;86:5674-5680.
-
(2001)
J Clin Endocrinol Metab
, vol.86
, pp. 5674-5680
-
-
Ross, J.L.1
Scott, C.2
Marttila, P.3
Kowal, K.4
Nass, A.5
Papenhausen, P.6
Abboudi, J.7
Os-terman, L.8
Kushner, H.9
Carter, P.10
Ezaki, M.11
Elder, F.12
Wei, F.13
Chen, H.14
Zinn, A.R.15
-
37
-
-
22144481004
-
The phenotypic spectrum of COL2A1 mutations
-
Nishimura G, Haga N, Kitoh H, Tanaka Y, Sonoda T, Kitamura M, Shirahama S, Itoh T, Nakashima E, Ohashi H, Ike-gawa S: The phenotypic spectrum of COL2A1 mutations. Hum Mutat 2005;26:36-43.
-
(2005)
Hum Mutat
, vol.26
, pp. 36-43
-
-
Nishimura, G.1
Haga, N.2
Kitoh, H.3
Tanaka, Y.4
Sonoda, T.5
Kitamura, M.6
Shirahama, S.7
Itoh, T.8
Nakashima, E.9
Ohashi, H.10
Ike-gawa, S.11
-
38
-
-
0029070079
-
Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene
-
Briggs MD, Hoffmann SMG, King LM, Olsen AS, Mohrenweiser H, Leroy JG, Mortier GR, Rimoin DL, Lachman RS, Gaines ES, Cekleniak JA, Knowlton RG, Cohn DH: Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene. Nat Genet 1995;10:330-336.
-
(1995)
Nat Genet
, vol.10
, pp. 330-336
-
-
Briggs, M.D.1
Hoffmann, S.M.G.2
King, L.M.3
Olsen, A.S.4
Mohrenweiser, H.5
Leroy, J.G.6
Mortier, G.R.7
Rimoin, D.L.8
Lachman, R.S.9
Gaines, E.S.10
Cekleniak, J.A.11
Knowlton, R.G.12
Cohn, D.H.13
-
39
-
-
0029952406
-
Natural history study of pseudoachondroplasia
-
McKeand J, Rotta J, Hecht JT: Natural history study of pseudoachondroplasia. Am J Med Genet 1996;63:406-410.
-
(1996)
Am J Med Genet
, vol.63
, pp. 406-410
-
-
McKeand, J.1
Rotta, J.2
Hecht, J.T.3
|